nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP1A2—Carmustine—malignant glioma	0.397	0.57	CbGbCtD
Anastrozole—CYP3A4—Temozolomide—malignant glioma	0.3	0.431	CbGbCtD
Anastrozole—Cerebral infarction—Carmustine—malignant glioma	0.00923	0.0398	CcSEcCtD
Anastrozole—Cerebral ischaemia—Temozolomide—malignant glioma	0.00601	0.026	CcSEcCtD
Anastrozole—Embolism—Temozolomide—malignant glioma	0.00453	0.0195	CcSEcCtD
Anastrozole—Cyst—Carmustine—malignant glioma	0.0045	0.0194	CcSEcCtD
Anastrozole—Digestion impaired—Temozolomide—malignant glioma	0.00435	0.0188	CcSEcCtD
Anastrozole—Thrombosis—Carmustine—malignant glioma	0.00425	0.0183	CcSEcCtD
Anastrozole—Influenza-like symptoms—Temozolomide—malignant glioma	0.00407	0.0176	CcSEcCtD
Anastrozole—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00393	0.017	CcSEcCtD
Anastrozole—Hepatotoxicity—Carmustine—malignant glioma	0.00389	0.0168	CcSEcCtD
Anastrozole—Hepatotoxicity—Temozolomide—malignant glioma	0.00376	0.0162	CcSEcCtD
Anastrozole—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00353	0.0152	CcSEcCtD
Anastrozole—Accidental injury—Carmustine—malignant glioma	0.0034	0.0147	CcSEcCtD
Anastrozole—Breast pain—Temozolomide—malignant glioma	0.00333	0.0144	CcSEcCtD
Anastrozole—Neck pain—Carmustine—malignant glioma	0.00304	0.0131	CcSEcCtD
Anastrozole—Pulmonary embolism—Carmustine—malignant glioma	0.00301	0.013	CcSEcCtD
Anastrozole—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00291	0.0125	CcSEcCtD
Anastrozole—Vaginal inflammation—Temozolomide—malignant glioma	0.00291	0.0125	CcSEcCtD
Anastrozole—Pulmonary embolism—Temozolomide—malignant glioma	0.00291	0.0125	CcSEcCtD
Anastrozole—Neuropathy—Carmustine—malignant glioma	0.00282	0.0122	CcSEcCtD
Anastrozole—Influenza like illness—Temozolomide—malignant glioma	0.00282	0.0122	CcSEcCtD
Anastrozole—Vaginal infection—Temozolomide—malignant glioma	0.00274	0.0118	CcSEcCtD
Anastrozole—Neuropathy—Temozolomide—malignant glioma	0.00273	0.0118	CcSEcCtD
Anastrozole—Neoplasm—Carmustine—malignant glioma	0.00272	0.0117	CcSEcCtD
Anastrozole—Neoplasm—Temozolomide—malignant glioma	0.00263	0.0113	CcSEcCtD
Anastrozole—Thrombophlebitis—Carmustine—malignant glioma	0.00252	0.0109	CcSEcCtD
Anastrozole—Swelling—Carmustine—malignant glioma	0.00247	0.0107	CcSEcCtD
Anastrozole—Thrombophlebitis—Temozolomide—malignant glioma	0.00244	0.0105	CcSEcCtD
Anastrozole—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00243	0.0105	CcSEcCtD
Anastrozole—Injury—Carmustine—malignant glioma	0.00237	0.0103	CcSEcCtD
Anastrozole—Hot flush—Temozolomide—malignant glioma	0.00225	0.00974	CcSEcCtD
Anastrozole—Menopausal symptoms—Temozolomide—malignant glioma	0.00224	0.00965	CcSEcCtD
Anastrozole—Liver function test abnormal—Carmustine—malignant glioma	0.00202	0.0087	CcSEcCtD
Anastrozole—Mood swings—Temozolomide—malignant glioma	0.002	0.00863	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0019	0.0082	CcSEcCtD
Anastrozole—Dysphagia—Carmustine—malignant glioma	0.00189	0.00815	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00186	0.00803	CcSEcCtD
Anastrozole—Dysphagia—Temozolomide—malignant glioma	0.00182	0.00787	CcSEcCtD
Anastrozole—Sweating increased—Temozolomide—malignant glioma	0.00178	0.00767	CcSEcCtD
Anastrozole—Bronchitis—Temozolomide—malignant glioma	0.00175	0.00757	CcSEcCtD
Anastrozole—Depression—Carmustine—malignant glioma	0.00168	0.00724	CcSEcCtD
Anastrozole—Weight increased—Temozolomide—malignant glioma	0.00166	0.00716	CcSEcCtD
Anastrozole—Weight decreased—Temozolomide—malignant glioma	0.00165	0.00712	CcSEcCtD
Anastrozole—Neuropathy peripheral—Carmustine—malignant glioma	0.00165	0.00712	CcSEcCtD
Anastrozole—Urinary tract infection—Carmustine—malignant glioma	0.00163	0.00706	CcSEcCtD
Anastrozole—Depression—Temozolomide—malignant glioma	0.00162	0.007	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00161	0.00696	CcSEcCtD
Anastrozole—Neuropathy peripheral—Temozolomide—malignant glioma	0.00159	0.00688	CcSEcCtD
Anastrozole—Urinary tract infection—Temozolomide—malignant glioma	0.00158	0.00682	CcSEcCtD
Anastrozole—Hepatobiliary disease—Temozolomide—malignant glioma	0.00154	0.00664	CcSEcCtD
Anastrozole—Sinusitis—Temozolomide—malignant glioma	0.00152	0.00658	CcSEcCtD
Anastrozole—Haemoglobin—Carmustine—malignant glioma	0.00152	0.00655	CcSEcCtD
Anastrozole—Haemorrhage—Carmustine—malignant glioma	0.00151	0.00652	CcSEcCtD
Anastrozole—Oedema peripheral—Carmustine—malignant glioma	0.00149	0.00642	CcSEcCtD
Anastrozole—Haemoglobin—Temozolomide—malignant glioma	0.00147	0.00633	CcSEcCtD
Anastrozole—Hepatitis—Temozolomide—malignant glioma	0.00146	0.0063	CcSEcCtD
Anastrozole—Haemorrhage—Temozolomide—malignant glioma	0.00146	0.0063	CcSEcCtD
Anastrozole—Pharyngitis—Temozolomide—malignant glioma	0.00145	0.00625	CcSEcCtD
Anastrozole—Oedema peripheral—Temozolomide—malignant glioma	0.00144	0.00621	CcSEcCtD
Anastrozole—Erythema multiforme—Temozolomide—malignant glioma	0.00138	0.00596	CcSEcCtD
Anastrozole—Alopecia—Carmustine—malignant glioma	0.00133	0.00576	CcSEcCtD
Anastrozole—Erythema—Carmustine—malignant glioma	0.00131	0.00568	CcSEcCtD
Anastrozole—Alopecia—Temozolomide—malignant glioma	0.00129	0.00557	CcSEcCtD
Anastrozole—Back pain—Carmustine—malignant glioma	0.00127	0.00549	CcSEcCtD
Anastrozole—Erythema—Temozolomide—malignant glioma	0.00127	0.00548	CcSEcCtD
Anastrozole—Dysgeusia—Temozolomide—malignant glioma	0.00124	0.00537	CcSEcCtD
Anastrozole—Back pain—Temozolomide—malignant glioma	0.00123	0.00531	CcSEcCtD
Anastrozole—Anaemia—Carmustine—malignant glioma	0.00121	0.00525	CcSEcCtD
Anastrozole—Ill-defined disorder—Temozolomide—malignant glioma	0.00118	0.00509	CcSEcCtD
Anastrozole—Leukopenia—Carmustine—malignant glioma	0.00118	0.00508	CcSEcCtD
Anastrozole—Anaemia—Temozolomide—malignant glioma	0.00117	0.00507	CcSEcCtD
Anastrozole—Angioedema—Temozolomide—malignant glioma	0.00116	0.00501	CcSEcCtD
Anastrozole—Malaise—Temozolomide—malignant glioma	0.00115	0.00495	CcSEcCtD
Anastrozole—Leukopenia—Temozolomide—malignant glioma	0.00114	0.00491	CcSEcCtD
Anastrozole—Hypertension—Carmustine—malignant glioma	0.00113	0.0049	CcSEcCtD
Anastrozole—Myalgia—Carmustine—malignant glioma	0.00112	0.00483	CcSEcCtD
Anastrozole—Chest pain—Carmustine—malignant glioma	0.00112	0.00483	CcSEcCtD
Anastrozole—Anxiety—Carmustine—malignant glioma	0.00112	0.00482	CcSEcCtD
Anastrozole—Cough—Temozolomide—malignant glioma	0.00111	0.00479	CcSEcCtD
Anastrozole—Hypertension—Temozolomide—malignant glioma	0.0011	0.00474	CcSEcCtD
Anastrozole—Confusional state—Carmustine—malignant glioma	0.00108	0.00467	CcSEcCtD
Anastrozole—Myalgia—Temozolomide—malignant glioma	0.00108	0.00467	CcSEcCtD
Anastrozole—Arthralgia—Temozolomide—malignant glioma	0.00108	0.00467	CcSEcCtD
Anastrozole—Anxiety—Temozolomide—malignant glioma	0.00108	0.00465	CcSEcCtD
Anastrozole—Oedema—Carmustine—malignant glioma	0.00107	0.00463	CcSEcCtD
Anastrozole—Discomfort—Temozolomide—malignant glioma	0.00107	0.00461	CcSEcCtD
Anastrozole—Infection—Carmustine—malignant glioma	0.00107	0.0046	CcSEcCtD
Anastrozole—Dry mouth—Temozolomide—malignant glioma	0.00106	0.00457	CcSEcCtD
Anastrozole—Confusional state—Temozolomide—malignant glioma	0.00105	0.00451	CcSEcCtD
Anastrozole—Anaphylactic shock—Temozolomide—malignant glioma	0.00104	0.00448	CcSEcCtD
Anastrozole—Oedema—Temozolomide—malignant glioma	0.00104	0.00448	CcSEcCtD
Anastrozole—Infection—Temozolomide—malignant glioma	0.00103	0.00445	CcSEcCtD
Anastrozole—Anorexia—Carmustine—malignant glioma	0.00102	0.00442	CcSEcCtD
Anastrozole—Hyperhidrosis—Temozolomide—malignant glioma	0.001	0.00433	CcSEcCtD
Anastrozole—Anorexia—Temozolomide—malignant glioma	0.000988	0.00427	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000977	0.00422	CcSEcCtD
Anastrozole—Insomnia—Carmustine—malignant glioma	0.00097	0.00419	CcSEcCtD
Anastrozole—Paraesthesia—Carmustine—malignant glioma	0.000963	0.00416	CcSEcCtD
Anastrozole—Dyspnoea—Carmustine—malignant glioma	0.000956	0.00413	CcSEcCtD
Anastrozole—Somnolence—Carmustine—malignant glioma	0.000954	0.00412	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000945	0.00408	CcSEcCtD
Anastrozole—Insomnia—Temozolomide—malignant glioma	0.000938	0.00405	CcSEcCtD
Anastrozole—Decreased appetite—Carmustine—malignant glioma	0.000933	0.00403	CcSEcCtD
Anastrozole—Paraesthesia—Temozolomide—malignant glioma	0.000931	0.00402	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Carmustine—malignant glioma	0.000926	0.004	CcSEcCtD
Anastrozole—Dyspnoea—Temozolomide—malignant glioma	0.000924	0.00399	CcSEcCtD
Anastrozole—Somnolence—Temozolomide—malignant glioma	0.000922	0.00398	CcSEcCtD
Anastrozole—Constipation—Carmustine—malignant glioma	0.000917	0.00396	CcSEcCtD
Anastrozole—Pain—Carmustine—malignant glioma	0.000917	0.00396	CcSEcCtD
Anastrozole—Dyspepsia—Temozolomide—malignant glioma	0.000913	0.00394	CcSEcCtD
Anastrozole—Decreased appetite—Temozolomide—malignant glioma	0.000901	0.00389	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000895	0.00386	CcSEcCtD
Anastrozole—Fatigue—Temozolomide—malignant glioma	0.000894	0.00386	CcSEcCtD
Anastrozole—Pain—Temozolomide—malignant glioma	0.000887	0.00383	CcSEcCtD
Anastrozole—Constipation—Temozolomide—malignant glioma	0.000887	0.00383	CcSEcCtD
Anastrozole—Feeling abnormal—Carmustine—malignant glioma	0.000884	0.00382	CcSEcCtD
Anastrozole—Gastrointestinal pain—Carmustine—malignant glioma	0.000877	0.00379	CcSEcCtD
Anastrozole—Feeling abnormal—Temozolomide—malignant glioma	0.000854	0.00369	CcSEcCtD
Anastrozole—Body temperature increased—Carmustine—malignant glioma	0.000848	0.00366	CcSEcCtD
Anastrozole—Abdominal pain—Carmustine—malignant glioma	0.000848	0.00366	CcSEcCtD
Anastrozole—Gastrointestinal pain—Temozolomide—malignant glioma	0.000848	0.00366	CcSEcCtD
Anastrozole—Urticaria—Temozolomide—malignant glioma	0.000824	0.00356	CcSEcCtD
Anastrozole—Abdominal pain—Temozolomide—malignant glioma	0.00082	0.00354	CcSEcCtD
Anastrozole—Body temperature increased—Temozolomide—malignant glioma	0.00082	0.00354	CcSEcCtD
Anastrozole—Hypersensitivity—Carmustine—malignant glioma	0.00079	0.00341	CcSEcCtD
Anastrozole—Asthenia—Carmustine—malignant glioma	0.00077	0.00332	CcSEcCtD
Anastrozole—Hypersensitivity—Temozolomide—malignant glioma	0.000764	0.0033	CcSEcCtD
Anastrozole—Asthenia—Temozolomide—malignant glioma	0.000744	0.00321	CcSEcCtD
Anastrozole—Diarrhoea—Carmustine—malignant glioma	0.000734	0.00317	CcSEcCtD
Anastrozole—Pruritus—Temozolomide—malignant glioma	0.000733	0.00317	CcSEcCtD
Anastrozole—Dizziness—Carmustine—malignant glioma	0.000709	0.00306	CcSEcCtD
Anastrozole—Diarrhoea—Temozolomide—malignant glioma	0.000709	0.00306	CcSEcCtD
Anastrozole—Dizziness—Temozolomide—malignant glioma	0.000686	0.00296	CcSEcCtD
Anastrozole—Vomiting—Carmustine—malignant glioma	0.000682	0.00294	CcSEcCtD
Anastrozole—Rash—Carmustine—malignant glioma	0.000676	0.00292	CcSEcCtD
Anastrozole—Dermatitis—Carmustine—malignant glioma	0.000676	0.00292	CcSEcCtD
Anastrozole—Headache—Carmustine—malignant glioma	0.000672	0.0029	CcSEcCtD
Anastrozole—Vomiting—Temozolomide—malignant glioma	0.000659	0.00285	CcSEcCtD
Anastrozole—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000657	0.00917	CbGpPWpGaD
Anastrozole—Rash—Temozolomide—malignant glioma	0.000654	0.00282	CcSEcCtD
Anastrozole—Dermatitis—Temozolomide—malignant glioma	0.000653	0.00282	CcSEcCtD
Anastrozole—Headache—Temozolomide—malignant glioma	0.000649	0.0028	CcSEcCtD
Anastrozole—Nausea—Carmustine—malignant glioma	0.000637	0.00275	CcSEcCtD
Anastrozole—Nausea—Temozolomide—malignant glioma	0.000616	0.00266	CcSEcCtD
Anastrozole—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000613	0.00855	CbGpPWpGaD
Anastrozole—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000583	0.00813	CbGpPWpGaD
Anastrozole—CYP19A1—FSH signaling pathway—RAF1—malignant glioma	0.000568	0.00792	CbGpPWpGaD
Anastrozole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000555	0.00775	CbGpPWpGaD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000529	0.00738	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.000524	0.0073	CbGpPWpGaD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000509	0.0071	CbGpPWpGaD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000503	0.00701	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—CYP2B6—malignant glioma	0.000496	0.00691	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.000489	0.00682	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.000477	0.00665	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.000468	0.00652	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000467	0.00651	CbGpPWpGaD
Anastrozole—CYP1A2—Tryptophan metabolism—CYP2C18—malignant glioma	0.000467	0.00651	CbGpPWpGaD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000442	0.00616	CbGpPWpGaD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000436	0.00608	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000435	0.00607	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—CYP2C18—malignant glioma	0.00043	0.00599	CbGpPWpGaD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00043	0.00599	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.000424	0.00591	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.000423	0.0059	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000413	0.00576	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—PML—malignant glioma	0.000395	0.00551	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000387	0.0054	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000377	0.00526	CbGpPWpGaD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000372	0.00519	CbGpPWpGaD
Anastrozole—CYP19A1—Tryptophan metabolism—MDM2—malignant glioma	0.000372	0.00519	CbGpPWpGaD
Anastrozole—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.00036	0.00502	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000358	0.00499	CbGpPWpGaD
Anastrozole—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000357	0.00498	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000353	0.00492	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—GSTT1—malignant glioma	0.000348	0.00485	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000336	0.00469	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000332	0.00462	CbGpPWpGaD
Anastrozole—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000331	0.00462	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.000329	0.00459	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—PTGS1—malignant glioma	0.000326	0.00454	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000306	0.00427	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000291	0.00406	CbGpPWpGaD
Anastrozole—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	0.000291	0.00405	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000287	0.00401	CbGpPWpGaD
Anastrozole—CYP19A1—FSH signaling pathway—AKT1—malignant glioma	0.000276	0.00385	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000272	0.0038	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000271	0.00378	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.000261	0.00364	CbGpPWpGaD
Anastrozole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000257	0.00358	CbGpPWpGaD
Anastrozole—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	0.000255	0.00355	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—RTEL1—malignant glioma	0.000244	0.0034	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.000242	0.00337	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—GSTP1—malignant glioma	0.000241	0.00336	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—GSTP1—malignant glioma	0.000238	0.00331	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000236	0.00329	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000232	0.00323	CbGpPWpGaD
Anastrozole—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	0.000225	0.00313	CbGpPWpGaD
Anastrozole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000219	0.00306	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000219	0.00306	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000216	0.00302	CbGpPWpGaD
Anastrozole—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000197	0.00274	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.00019	0.00265	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.000188	0.00263	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000188	0.00262	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	0.000187	0.00261	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	0.000185	0.00258	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000179	0.0025	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000174	0.00243	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.000172	0.00239	CbGpPWpGaD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000169	0.00236	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000168	0.00235	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	0.000163	0.00227	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	0.00016	0.00224	CbGpPWpGaD
Anastrozole—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	0.000156	0.00217	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000154	0.00215	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000148	0.00207	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.000146	0.00203	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000145	0.00202	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000144	0.00201	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.000144	0.002	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000143	0.00199	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.000141	0.00197	CbGpPWpGaD
Anastrozole—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	0.000141	0.00196	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.00014	0.00195	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—COX8A—malignant glioma	0.00014	0.00195	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.000136	0.00189	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTT1—malignant glioma	0.000131	0.00183	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.000129	0.00179	CbGpPWpGaD
Anastrozole—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000127	0.00177	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.000126	0.00176	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.000126	0.00175	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000125	0.00175	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000125	0.00174	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000124	0.00173	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—PTGS1—malignant glioma	0.000123	0.00172	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000121	0.00168	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ASMT—malignant glioma	0.000119	0.00166	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000116	0.00162	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—BCAN—malignant glioma	0.000112	0.00156	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000109	0.00152	CbGpPWpGaD
Anastrozole—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000109	0.00151	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000108	0.0015	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000107	0.00149	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000107	0.00149	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000105	0.00147	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000101	0.00141	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.0001	0.0014	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	9.83e-05	0.00137	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	9.82e-05	0.00137	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	9.61e-05	0.00134	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	9.61e-05	0.00134	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—PTGS1—malignant glioma	9.51e-05	0.00133	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	9.28e-05	0.00129	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—RTEL1—malignant glioma	9.21e-05	0.00128	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	9.15e-05	0.00128	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	9.15e-05	0.00128	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTP1—malignant glioma	9.11e-05	0.00127	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	9.08e-05	0.00127	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—IDH2—malignant glioma	9.02e-05	0.00126	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	8.99e-05	0.00125	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.5e-05	0.00119	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP2B6—malignant glioma	8.48e-05	0.00118	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—malignant glioma	8.24e-05	0.00115	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—IDH1—malignant glioma	7.75e-05	0.00108	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.7e-05	0.00107	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SPHK1—malignant glioma	7.5e-05	0.00105	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.45e-05	0.00104	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP2C18—malignant glioma	7.35e-05	0.00103	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—RTEL1—malignant glioma	7.11e-05	0.000992	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTP1—malignant glioma	7.03e-05	0.000981	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	6.96e-05	0.000971	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	6.93e-05	0.000967	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.93e-05	0.000967	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.58e-05	0.000918	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.37e-05	0.000888	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.31e-05	0.00088	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—COX8A—malignant glioma	6.19e-05	0.000864	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.09e-05	0.00085	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTT1—malignant glioma	5.94e-05	0.000829	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTGS1—malignant glioma	5.57e-05	0.000777	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.55e-05	0.000774	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.53e-05	0.000772	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—COX8A—malignant glioma	5.29e-05	0.000738	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ASMT—malignant glioma	5.26e-05	0.000734	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—BCHE—malignant glioma	5.18e-05	0.000722	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.15e-05	0.000718	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SLC5A5—malignant glioma	5.12e-05	0.000713	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—BCAN—malignant glioma	4.95e-05	0.00069	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.84e-05	0.000675	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.79e-05	0.000668	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.73e-05	0.00066	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ASMT—malignant glioma	4.5e-05	0.000627	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.4e-05	0.000613	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—BCAN—malignant glioma	4.23e-05	0.00059	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.18e-05	0.000583	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTP1—malignant glioma	4.12e-05	0.000575	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—COX8A—malignant glioma	4.08e-05	0.000569	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CAT—malignant glioma	4.01e-05	0.000559	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—IDH2—malignant glioma	3.99e-05	0.000556	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NCOR1—malignant glioma	3.79e-05	0.000528	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.76e-05	0.000525	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP2B6—malignant glioma	3.75e-05	0.000523	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ASMT—malignant glioma	3.47e-05	0.000484	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—IDH1—malignant glioma	3.43e-05	0.000478	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—IDH2—malignant glioma	3.41e-05	0.000475	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SPHK1—malignant glioma	3.32e-05	0.000463	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—BCAN—malignant glioma	3.26e-05	0.000455	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP2C18—malignant glioma	3.25e-05	0.000454	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.21e-05	0.000448	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.21e-05	0.000447	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CAV1—malignant glioma	3.09e-05	0.00043	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.07e-05	0.000428	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.95e-05	0.000411	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—IDH1—malignant glioma	2.93e-05	0.000409	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SPHK1—malignant glioma	2.84e-05	0.000396	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CG—malignant glioma	2.81e-05	0.000392	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.79e-05	0.00039	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP2C18—malignant glioma	2.78e-05	0.000388	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PPARG—malignant glioma	2.71e-05	0.000378	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.7e-05	0.000376	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—IDH2—malignant glioma	2.63e-05	0.000367	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTT1—malignant glioma	2.63e-05	0.000367	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.62e-05	0.000366	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.47e-05	0.000345	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CD—malignant glioma	2.47e-05	0.000345	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTGS1—malignant glioma	2.46e-05	0.000344	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.46e-05	0.000343	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.39e-05	0.000333	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.3e-05	0.000321	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—BCHE—malignant glioma	2.29e-05	0.00032	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.26e-05	0.000316	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—IDH1—malignant glioma	2.26e-05	0.000316	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTT1—malignant glioma	2.25e-05	0.000313	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SPHK1—malignant glioma	2.19e-05	0.000305	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CB—malignant glioma	2.15e-05	0.0003	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.14e-05	0.000299	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.14e-05	0.000299	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTGS2—malignant glioma	2.13e-05	0.000298	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.12e-05	0.000296	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTGS1—malignant glioma	2.11e-05	0.000294	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.1e-05	0.000293	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—BCHE—malignant glioma	1.96e-05	0.000273	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.93e-05	0.00027	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTEN—malignant glioma	1.86e-05	0.00026	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.85e-05	0.000258	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.83e-05	0.000255	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTP1—malignant glioma	1.82e-05	0.000254	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.81e-05	0.000253	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CAT—malignant glioma	1.77e-05	0.000247	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTT1—malignant glioma	1.73e-05	0.000242	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NCOR1—malignant glioma	1.68e-05	0.000234	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTGS1—malignant glioma	1.63e-05	0.000227	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.58e-05	0.00022	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTP1—malignant glioma	1.56e-05	0.000217	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CAT—malignant glioma	1.52e-05	0.000211	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—BCHE—malignant glioma	1.51e-05	0.000211	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.49e-05	0.000208	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NCOR1—malignant glioma	1.43e-05	0.0002	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CAV1—malignant glioma	1.37e-05	0.00019	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CA—malignant glioma	1.31e-05	0.000183	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.3e-05	0.000182	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.24e-05	0.000174	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTP1—malignant glioma	1.2e-05	0.000168	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PPARG—malignant glioma	1.2e-05	0.000167	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CAT—malignant glioma	1.17e-05	0.000163	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CAV1—malignant glioma	1.17e-05	0.000163	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.12e-05	0.000156	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NCOR1—malignant glioma	1.1e-05	0.000154	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.09e-05	0.000153	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—AKT1—malignant glioma	1.07e-05	0.00015	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.06e-05	0.000148	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PPARG—malignant glioma	1.03e-05	0.000143	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CB—malignant glioma	9.53e-06	0.000133	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTGS2—malignant glioma	9.45e-06	0.000132	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CD—malignant glioma	9.35e-06	0.00013	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CAV1—malignant glioma	9.01e-06	0.000126	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTEN—malignant glioma	8.24e-06	0.000115	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CG—malignant glioma	8.21e-06	0.000114	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CB—malignant glioma	8.15e-06	0.000114	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTGS2—malignant glioma	8.07e-06	0.000113	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PPARG—malignant glioma	7.92e-06	0.00011	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CD—malignant glioma	7.21e-06	0.000101	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTEN—malignant glioma	7.04e-06	9.82e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.29e-06	8.77e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTGS2—malignant glioma	6.23e-06	8.69e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CA—malignant glioma	5.81e-06	8.1e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTEN—malignant glioma	5.43e-06	7.58e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CA—malignant glioma	4.97e-06	6.93e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—AKT1—malignant glioma	4.75e-06	6.62e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—AKT1—malignant glioma	4.06e-06	5.66e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.83e-06	5.35e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—AKT1—malignant glioma	3.13e-06	4.37e-05	CbGpPWpGaD
